SCHEMBL10183654

SCHEMBL10183654

O=C1C(N(C(=O)CNC2CCCC2)c2cccc(F)c2)c2ccccc2N1C1CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 10/20 0.38
▸ LMNA P02545 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ OPRM1 P35372 2/20 0.37
▸ OPRK1 P41145 2/20 0.37
▸ OPRL1 P41146 2/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ CCKAR P32238 2/20 0.35
▸ CCKBR P32239 2/20 0.35
▸ AGTR2 P50052 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183782 0.90 OPRM1 (0.40) IDH1LMNATP53MAPTOPRM1
SCHEMBL10183659 0.90 OPRM1 (0.36) IDH1LMNATP53MAPTOPRM1
SCHEMBL10184071 0.89 OPRM1 (0.37) IDH1LMNATP53MAPTOPRM1
SCHEMBL10183299 0.88 OPRM1 (0.40) IDH1LMNATP53MAPTOPRM1
SCHEMBL10183669 0.88 CCKBR (0.41) IDH1LMNATP53MAPTOPRM1
SCHEMBL10183337 0.87 OPRM1 (0.39) IDH1LMNATP53MAPTOPRM1
SCHEMBL10183319 0.87 MEN1 (0.43) IDH1LMNATP53MAPTOPRM1
SCHEMBL10185977 0.87 OPRM1 (0.39) IDH1LMNATP53MAPTOPRM1
SCHEMBL10183927 0.87 OPRM1 (0.36) IDH1LMNATP53MAPTOPRM1
SCHEMBL10183616 0.87 OPRM1 (0.36) IDH1LMNATP53MAPTOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback